| Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes M Gannagé, D Dormann, R Albrecht, J Dengjel, T Torossi, PC Rämer, ... Cell host & microbe 6 (4), 367-380, 2009 | 586 | 2009 |
| EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors RE White, PC Rämer, KN Naresh, S Meixlsperger, L Pinaud, C Rooney, ... The Journal of clinical investigation 122 (4), 2012 | 188 | 2012 |
| Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence T Strowig, O Chijioke, P Carrega, F Arrey, S Meixlsperger, PC Rämer, ... Blood, The Journal of the American Society of Hematology 116 (20), 4158-4167, 2010 | 141 | 2010 |
| CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice S Meixlsperger, CS Leung, PC Rämer, M Pack, LD Vanoaica, G Breton, ... Blood, The Journal of the American Society of Hematology 121 (25), 5034-5044, 2013 | 140 | 2013 |
| Dual-track clearance of circulating bacteria balances rapid restoration of blood sterility with induction of adaptive immunity SP Broadley, A Plaumann, R Coletti, C Lehmann, A Wanisch, ... Cell host & microbe 20 (1), 36-48, 2016 | 128 | 2016 |
| Persistent KSHV infection increases EBV-associated tumor formation in vivo via enhanced EBV lytic gene expression D McHugh, N Caduff, MHM Barros, PC Rämer, A Raykova, A Murer, ... Cell host & microbe 22 (1), 61-73. e7, 2017 | 120 | 2017 |
| Adoptive Transfer of EBV Specific CD8+ T Cell Clones Can Transiently Control EBV Infection in Humanized Mice O Antsiferova, A Müller, PC Rämer, O Chijioke, B Chatterjee, A Raykova, ... PLoS pathogens 10 (8), e1004333, 2014 | 79 | 2014 |
| Mice with human immune system components as in vivo models for infections with human pathogens PC Rämer, O Chijioke, S Meixlsperger, CS Leung, C Münz Immunology and cell biology 89 (3), 408-416, 2011 | 70 | 2011 |
| Statins inhibit NK‐cell cytotoxicity by interfering with LFA‐1‐mediated conjugate formation PC Raemer, K Kohl, C Watzl European journal of immunology 39 (6), 1456-1465, 2009 | 46 | 2009 |
| Endothelial progenitor cells possess monocyte-like antigen-presenting and T-cell-co-stimulatory capacity PC Raemer, S Haemmerling, T Giese, DH Canaday, HA Katus, ... Transplantation 87 (3), 340-349, 2009 | 39 | 2009 |
| Targeting Beclin 1 for viral subversion of macroautophagy M Gannagé, PC Rämer, C Münz Autophagy 6 (1), 166-167, 2010 | 36 | 2010 |
| Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice N Caduff, D McHugh, A Murer, P Rämer, A Raykova, V Landtwing, ... PLoS pathogens 16 (4), e1008477, 2020 | 19 | 2020 |
| Human lysosomal acid lipase inhibitor lalistat impairs Mycobacterium tuberculosis growth by targeting bacterial hydrolases J Lehmann, J Vomacka, K Esser, M Nodwell, K Kolbe, P Rämer, U Protzer, ... MedChemComm 7 (9), 1797-1801, 2016 | 19 | 2016 |
| Epstein-Barr viruses (EBVs) deficient in EBV-encoded RNAs have higher levels of latent membrane protein 2 RNA expression in lymphoblastoid cell lines and efficiently establish … G Gregorovic, EA Boulden, R Bosshard, C Elgueta Karstegl, R Skalsky, ... Journal of virology 89 (22), 11711-11714, 2015 | 19 | 2015 |
| Epstein-Barr viruses deficient in EBER RNAs give higher LMP2 RNA expression in lymphoblastoid cell lines and efficiently establish persistent infection in humanized mice G Gregorovic, EA Boulden, R Bosshard, CE Karstegl, R Skalsky, ... J. Virol 89, 11711-11714, 2015 | 9 | 2015 |
| Are enterococcal bloodstream infections an independent risk factor for a poorer 5-year survival or just a marker for severity of illness?—The Munich multicentric enterococci … K Rothe, T Bachfischer, S Karapetyan, A Hapfelmeier, M Wurst, S Gleich, ... Microbiology Spectrum 11 (6), e02585-23, 2023 | 1 | 2023 |
| Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice N Caduff, D McHugh, A Murer, P Rämer, A Raykova, V Landtwing, ... PLoS Pathogens 16 (12), e1009167, 2020 | 1 | 2020 |
| Integrated IT platform for coordination of diagnosis, treatment, and aftercare of prosthetic joint infections C Suren, S Feihl, C Querbach, P Raemer, F Pohlig, J Thurner, R Bernard, ... in vivo 33 (5), 1625-1633, 2019 | 1 | 2019 |
| Complement-and platelet-mediated shuttling of blood-borne bacteria to CD8a+ dendritic cells S Broadley, A Plaumann, A Seidlmeier, A Wanisch, S Luo, P Raemer, ... Molecular Immunology 3 (56), 266, 2013 | | 2013 |
| Immune control of a human tumorvirus in vivo C Muenz, PC Raemer, RE White, MJ Allday ONKOLOGIE 35, 240-240, 2012 | | 2012 |
